Palvella Therapeutics (PVLA) EBT Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.54% |
| Dec 31, 2025 | 34.14% |
| Sep 30, 2025 | 2.60% |
| Jun 30, 2025 | -15.91% |
| Mar 31, 2025 | -18.27% |
| Dec 31, 2024 | 81.11% |
| Sep 30, 2024 | -21.19% |
| Jun 30, 2024 | 18.72% |
| Mar 31, 2024 | 24.52% |
| Dec 31, 2023 | 25.63% |
| Sep 30, 2023 | -12.84% |
| Jun 30, 2023 | 56.12% |
| Mar 31, 2023 | -11.70% |
| Sep 30, 2022 | -11.53% |
| Jun 30, 2022 | -5.64% |
| Mar 31, 2022 | 1.37% |
| Dec 31, 2021 | -11.46% |
| Sep 30, 2021 | -25.13% |
| Jun 30, 2021 | -23.29% |
| Mar 31, 2021 | -3.97% |
| Dec 31, 2020 | -35.27% |
| Sep 30, 2020 | -27.24% |
| Jun 30, 2020 | -5.10% |
| Mar 31, 2020 | 0.92% |
| Sep 30, 2019 | -5.09% |
| Jun 30, 2019 | -32.48% |
| Mar 31, 2019 | -67.71% |
| Dec 31, 2018 | -457.58% |
| Sep 30, 2018 | -303.37% |
| Jun 30, 2018 | -318.32% |